Staying Safe Intervention: Preventing HCV Among Youth Opioid Injectors
Funded by: National Institute on Drug Abuse
Project dates: July 2016 - May 2023
Principal Investigator: Mateu-Gelabert, Pedro
Principal Investigator: Guarino, Honoria

Young people who inject drugs are at extremely high risk for HCV infection through the use of contaminated injection equipment. To date, no behavioral intervention has been sufficiently potent to produce significant reductions in HCV incidence among PWID. To address this need, the project is developing Staying Safe (Ssafe), an innovative, strengths-based, socio-behavioral HCV prevention intervention. This study will assess the effectiveness of the Ssafe intervention in reducing both injection-related HCV and HIV risk behavior and HCV incidence among young adults (ages 18-29) who inject opioids (heroin and/or prescription opioids).

Abstract on NIH RePORTER